Abstract
ObjectiveTo evaluate the comparative efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on glycaemic control, body weight, and lipid profile in adults with type 2 diabetes.DesignSystematic review and network...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have